Abstract:ETHNOPHARMACOLOGICAL RELEVANCE:Polysaccharides and small molecules commonly co-exist in decoctions of traditional Chinese medicines (TCMs). Our previous study outlined that ginseng polysaccharides (GP) could interact with co-existing ginsenosides to produce synergistic effect in an over-fatigue and acute cold stress model via gut microbiota involved mechanisms.AIM OF THE STUDY:This study aimed to verify the interactions by examining the impact of GP on oral pharmacokinetics of ginsenoside Rb1 (Rb1), the dominant protopanoxadiol (PPD)-type ginsenoside in Ginseng, on a dextran sulphate sodium (DSS) induced experimental colitis model which was characterized by gut dysbiosis, and to delineate the underlying mechanisms in vitro.MATERIALS AND METHODS:Rats received drinking water (normal group), 5% DSS (UC group), or 5% DSS plus daily oral administration of GP (GP group) for 7 days and fecal samples were collected on day -3, 0 and 6. On day 7 all animals received an oral dosage of Rb1 and blood samples were withdrawn for pharmacokinetic study. The in vitro metabolism study of Rb1 in gut microbiota from normal and UC rats and the transport study of Rb1 across Caco-2 cell monolayer were carried out in presence/absence of GP. Rb1 and its bacterial metabolites ginsenoside Rd (Rd), ginsenoside F2 (F2), Compound K (CK) and PPD were determined using LC-MS/MS. Total and target bacteria in fecal samples were determined by using 16S rRNA-based RT-PCR. β-Glucosidase activity was determined by measuring 4-nitrophenol formed from 4-nitrophenyl-β-D-glucopyranoside hydrolysis.RESULTS:DSS induction did not alter AUC0-t and Cmax of Rb1, which, however, were doubled together with elevated AUC0-t of the metabolites, in particular Rd and CK, in GP group. GP influenced the microbial composition and showed a prebiotic-like effect. Accordingly, GP treatment could partially restore the β-glucosidase activity which was reduced by DSS induction. The presence of GP resulted in quicker microbial metabolism of Rb1 and higher Rd formation in first 8 h of incubation, while the impact on F2 and CK formation/conversion became obvious after 8 h. More interestingly, GP slightly stimulated Caco-2 cell growth and facilitated Rb1 transport across the Caco-2 monolayer in both directions, increasing the Papp of Rb1 from 10-7 cm/s to 10-6 cm/s.CONCLUSIONS:GP alleviated DSS-induced colitis-like symptoms and enhanced the systemic exposure of Rb1 through enhancing microbial deglycosylation and intestinal epithelial absorption of Rb1. These findings further demonstrated the important role of gut microbiota in the multifaceted action of polysaccharides in the holistic actions of traditional decoction of TCMs.

Metabolome and Gut Microbiota Variation with Long-Term Intake of Panax Ginseng Extracts on Rats

Effect of Long-Term Intake of Ginseng Extracts on Gut Microbiota in Rats

Metabolic Characteristics of Ginsenosides from Panax Ginseng in Rat Feces Mediated by Gut Microbiota.

[Urine Metabonomic Study on Long-Term Use of Total Ginsenosides in Rats].

Metabolite profiling of ginsenosides in rat plasma, urine, and faeces by LC-MS/MS and its application to a pharmacokinetic study after oral administration of Panax ginseng extract.

Microbiota, Co-Metabolites, and Network Pharmacology Reveal the Alteration of the Ginsenoside Fraction on Inflammatory Bowel Disease.

Biotransformation of Panax Ginseng Extract by Rat Intestinal Microflora: Identification and Quantification of Metabolites Using Liquid Chromatography-Tandem Mass Spectrometry

Ginseng Polysaccharides Enhanced Ginsenoside Rb1 and Microbial Metabolites Exposure Through Enhancing Intestinal Absorption and Affecting Gut Microbial Metabolism.

Qualitatively and quantitatively investigating the metabolism of 20(S)-protopanaxadiol-type ginsenosides by gut microbiota of different species

Integrated anti-fatigue effects of polysaccharides and small molecules coexisting in water extracts of ginseng: Gut microbiota-mediated mechanisms

Significant Difference In Active Metabolite Levels Of Ginseng In Humans Consuming Asian Or Western Diet: The Link With Enteric Microbiota

Distinct Urine Metabolome after Asian Ginseng and American Ginseng Intervention Based on GC-MS Metabolomics Approach

Gut Microbiota: Therapeutic Targets of Ginseng Against Multiple Disorders and Ginsenoside Transformation

Current View on How Human Gut Microbiota Mediate Metabolic and Pharmacological Activity of Panax ginseng. A Scoping Review

Metabonomics Approach to Comparing the Anti-stress Effects of Four Panax Ginseng Components in Rats.

Fecal Metabolomic Dataset of American Ginseng-Treated DSS Mice: Correlation Between Ginseng Enteric Inflammation Inhibition and Its Biological Signatures

Gc-Ms Metabolomic Analysis To Reveal The Metabolites And Biological Pathways Involved In The Developmental Stages And Tissue Response Of Panax Ginseng

Insight Into Polysaccharides From Panax ginseng C. A. Meyer in Improving Intestinal Inflammation: Modulating Intestinal Microbiota and Autophagy

Comparative Characterization of the Ginsenosides from Six Panax Herbal Extracts and Their in Vitro Rat Gut Microbial Metabolites by Advanced Liquid Chromatography-Mass Spectrometry Approaches.

Comprehensive fecal metabolomics and gut microbiota for the evaluation of the mechanism of Panax Ginseng in the treatment of Qi-deficiency liver cancer

Pharmacokinetic Studies of Chemical Constituents of Ginseng